Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma
-
Soriano, Aroa (Hospital Universitari Vall d'Hebron)
;
Masanas, Marc (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Boloix, Ariadna (Institut de Ciència de Materials de Barcelona) ;
Masiá, Núria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
París-Coderch, Laia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Piskareva, Olga (Royal College of Surgeons in Ireland and National Children's Research Centre Our Lady's Children's Hospital. Molecular and Cellular Therapeutics) ;
Jiménez Jiménez, Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Henrich, Kai-Oliver (German Cancer Research Center (DKFZ). Neuroblastoma Genomics Group) ;
Roma, Josep (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Westermann, Frank (German Cancer Research Center (DKFZ). Neuroblastoma Genomics Group) ;
Stallings, Raymond L. (Royal College of Surgeons in Ireland and National Children's Research Centre Our Lady's Children's Hospital. Molecular and Cellular Therapeutics) ;
Sábado, Constantino (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Toledo, Josep Sánchez (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Santamaría Margalef, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gallego, Soledad (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Segura, Miguel F. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona ;
Hospital Universitari Vall d'Hebron
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
